Showing results (121-130 of 206) with videos related to
Sort By:
Pageof 21
Mbio|September 12, 2024
Antibody sequence determinants of viral antigen specificityAlexandra A Abu-Shmais, Matthew J Vukovich, Perry T Wasdin, et al.Journal of Virology|July 12, 2013
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strainsGwo-Yu Chuang, Priyamvada Acharya, Stephen D Schmidt, et al.Journal of Virology|September 23, 2016
Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary BindingNancy S Longo, Matthew S Sutton, Andrea R Shiakolas, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Prefusion-specific glycoprotein B human antibodies protect against neonatal HSV-2 infectionParastoo Amlashi, Jeongryeol Kim, Nisali N Mendis, et al.Cell Host & Microbe|June 5, 2018
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 InfectionIan Setliff, Wyatt J McDonnell, Nagarajan Raju, et al.Journal of Virology|December 12, 2023
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccinesMatthew J Vukovich, Nagarajan Raju, Prudence Kgagudi, et al.Biorxiv : the Preprint Server for Biology|June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blockingAndrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.Cell|April 2, 2013
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralizationFlorian Klein, Ron Diskin, Johannes F Scheid, et al.Journal of Virology|March 20, 2015
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus InfectionKevin O Saunders, Amarendra Pegu, Ivelin S Georgiev, et al.Nature Biotechnology|March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blockingAndrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.Pageof 21